logo

Allakos Inc. (ALLK)



Trade ALLK now with
  Date
  Headline
10/26/2020 7:03:43 AM Allakos Announces Results From Phase 1 Study Of Subcutaneously Administered Lirentelimab
6/3/2020 8:13:11 AM Allakos Says Recruiting Patients For Two Registrational Clinical Studies Of AK002
5/4/2020 8:11:36 AM Allakos Reports Results From Long-term OLE Study Of Antolimab
8/13/2018 7:29:19 AM William Blair Initiates Allakos Inc. (ALLK) At Outperform